+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nucleic Acids for Molecular Diagnosis Market - Global Forecast 2026-2032- Product Image
Nucleic Acids for Molecular Diagnosis Market - Global Forecast 2026-2032- Product Image
Sale

Nucleic Acids for Molecular Diagnosis Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6146669
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nucleic Acids for Molecular Diagnosis Market is projected to reach USD 2.80 Billion in 2026. It is expected to continue growing at a CAGR of 10.48%, reaching USD 5.15 Billion by 2032.

Nucleic Acids for Molecular Diagnosis: Executive Overview

Nucleic acids-including DNA, RNA, and their engineered derivatives-are central to molecular diagnosis because they enable the direct detection, identification, and characterization of pathogens, genetic variants, and disease-associated biomarkers. The field spans sample preparation, amplification, sequencing, hybridization, and signal-detection workflows across infectious disease, oncology, inherited disorders, reproductive health, and other clinical applications. Its development is shaped by analytical performance, turnaround time, workflow integration, reimbursement, laboratory capacity, and regulatory requirements.

From Centralized Testing to Integrated, Decentralized Workflows

Molecular diagnosis is shifting from highly centralized laboratory models toward more distributed and connected workflows. Multiplex assays, cartridge-based systems, automated extraction, near-patient testing, and laboratory information-system integration are reducing manual steps while increasing the importance of quality control and interoperability. At the same time, laboratories are balancing rapid results with confirmatory testing, biosafety, specimen stability, contamination control, and the need to validate assays across diverse populations and clinical settings.

Artificial Intelligence Strengthens Interpretation and Workflow Management

Artificial intelligence is increasingly applied to assay design, primer and probe selection, variant interpretation, image and signal analysis, quality monitoring, and laboratory operations. Its practical value depends on well-curated datasets, transparent validation, representative training populations, and integration with established molecular workflows. AI can help prioritize clinically relevant findings and identify anomalous results, but it does not remove the need for analytical validation, clinical correlation, human oversight, cybersecurity, or compliance with applicable medical-device and data-protection rules.

Regional Differences Reflect Infrastructure, Regulation, and Access

North America combines advanced laboratory infrastructure, strong translational research, and sophisticated reimbursement and regulatory environments, while access and testing economics vary by jurisdiction. Europe emphasizes harmonized standards, cross-border data governance, and decentralized healthcare delivery, with implementation differing among countries. Asia-Pacific includes highly developed molecular-testing systems alongside rapidly expanding capacity and substantial variation in infrastructure, population diversity, and regulatory maturity. Latin America is characterized by uneven laboratory access, public-health priorities, and growing interest in locally adaptable workflows. The Middle East is investing in specialized diagnostics, genomics, and healthcare modernization, while the region continues to address workforce and referral-network requirements. Africa presents major opportunities for decentralized and resilient testing, with adoption influenced by supply chains, financing, biosafety, local manufacturing, and the integration of molecular diagnosis into infectious-disease and broader primary-care programs.

Economic and Policy Groups Reveal Different Adoption Conditions

ASEAN markets reflect diverse regulatory systems, healthcare financing models, and laboratory capabilities, making interoperability, training, and scalable sample-to-answer workflows especially relevant. BRICS members combine major scientific and manufacturing capabilities with substantial differences in public-health priorities, procurement, and access. The European Union benefits from coordinated regulatory and data frameworks, although national reimbursement and implementation remain important. G7 countries generally support advanced research, quality systems, and precision-medicine infrastructure, while facing cost, workforce, and data-governance pressures. GCC states are strengthening centralized and specialized diagnostic capacity through healthcare modernization initiatives, with continued attention to local skills and sustainable procurement. NATO members show strong demand for resilient diagnostics, biosafety, and supply-chain continuity, alongside their civilian healthcare responsibilities.

Country-Level Priorities Span Innovation, Access, and Resilience

Australia is focused on geographically adaptable access and genomic capability; Brazil on expanding equitable testing across a large and diverse health system; Canada on integrated public healthcare delivery and access across remote communities; and China on domestic capability, scale, and integration of molecular technologies. France, Germany, Italy, and Spain are shaped by European regulatory requirements alongside national reimbursement, laboratory organization, and public-health priorities. India is balancing high-volume diagnostic needs, affordability, decentralization, and domestic manufacturing. Japan emphasizes precision, quality assurance, and an aging-population context, while South Korea combines advanced digital infrastructure with strong biotechnology capabilities. Mexico is addressing regional disparities and laboratory-network development. Russia’s landscape is influenced by domestic supply, public-health requirements, and access to specialized technologies. The United Kingdom continues to emphasize genomics, centralized expertise, and health-system integration. The United States remains a major environment for innovation, clinical adoption, regulatory development, and reimbursement debate, with persistent variation across care settings and populations.

Prioritize Validated, Interoperable, and Equitable Molecular Workflows

Industry leaders should prioritize end-to-end performance rather than isolated assay attributes. Investments should focus on robust sample-to-answer workflows, internal controls, contamination prevention, clear result interpretation, and interoperability with laboratory and clinical systems. Product strategies should address decentralized settings without compromising confirmatory pathways, operator training, serviceability, and quality management. Organizations should validate performance across relevant specimen types and demographic groups, maintain transparent evidence for regulators and clinicians, and design AI features with human review, auditability, cybersecurity, and bias monitoring. Regional strategies should align with local reimbursement, procurement, regulatory, workforce, and supply-chain conditions, while partnerships with laboratories, public-health agencies, and healthcare providers can improve implementation and trust.

Methodology for Assessing the Molecular-Diagnosis Landscape

This executive summary uses a qualitative market-structure approach centered on the role of nucleic acids in molecular diagnosis. The assessment organizes evidence by technology workflow, clinical use, healthcare setting, geography, economic grouping, regulation, infrastructure, and implementation conditions. It considers analytical validity, clinical utility, workflow integration, access, workforce, data governance, supply-chain resilience, and the implications of artificial intelligence. Regional, group, and country observations are framed as contextual comparisons rather than market estimates or forecasts, and conclusions are limited to evidence-supported structural themes.

Execution Quality Will Determine the Next Phase of Adoption

Nucleic acids for molecular diagnosis are becoming more deeply embedded in clinical and public-health decision-making, but progress depends on more than assay innovation. Reliable implementation requires validated workflows, fit-for-purpose infrastructure, skilled personnel, responsible data practices, sustainable procurement, and equitable access. Leaders that connect technological performance with clinical utility, regulatory readiness, interoperability, and local operating realities will be best positioned to translate molecular capabilities into dependable diagnostic value.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Nucleic Acids for Molecular Diagnosis Market, by Product
7.1. Introduction
7.2. Instruments
7.2.1. Microarray Platforms
7.2.2. Qpcr Systems
7.2.3. Sequencers
7.3. Reagents And Kits
7.3.1. Microarray Kits
7.3.2. Ngs Library Preparation Kits
7.3.3. Pcr Reagents
7.4. Services
7.4.1. Bioinformatics Services
7.4.2. Laboratory Services
7.4.3. Sequencing Services
8. Nucleic Acids for Molecular Diagnosis Market, by Technology
8.1. Introduction
8.2. Microarrays
8.2.1. Gene Expression Arrays
8.2.2. Genotyping Arrays
8.3. Next Generation Sequencing
8.3.1. Rna Sequencing
8.3.2. Targeted Sequencing
8.3.3. Whole Genome Sequencing
8.4. Pcr
8.4.1. Conventional Pcr
8.4.2. Digital Pcr
8.4.3. Real-Time Pcr
9. Nucleic Acids for Molecular Diagnosis Market, by Nucleic Acid Type
9.1. Introduction
9.2. Dna
9.2.1. Cdna
9.2.2. Genomic Dna
9.3. Rna
9.3.1. Microrna Analysis
9.3.2. Mrna Analysis
10. Nucleic Acids for Molecular Diagnosis Market, by Application
10.1. Introduction
10.2. Genetic Testing
10.2.1. Carrier Testing
10.2.2. Pharmacogenomic Testing
10.2.3. Predictive Testing
10.3. Infectious Disease
10.3.1. Bacterial Disease Testing
10.3.2. Parasitic Disease Testing
10.3.3. Viral Disease Testing
10.4. Oncology
10.4.1. Hematological Cancer Testing
10.4.2. Solid Tumor Testing
10.5. Prenatal Testing
10.5.1. Invasive Prenatal Testing
10.5.2. Non-invasive Prenatal Testing
11. Nucleic Acids for Molecular Diagnosis Market, by End User
11.1. Introduction
11.2. Academic And Research
11.3. Biopharmaceutical Companies
11.4. Diagnostic Laboratories
11.5. Hospitals And Clinics
12. Nucleic Acids for Molecular Diagnosis Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Nucleic Acids for Molecular Diagnosis Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Nucleic Acids for Molecular Diagnosis Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Agilent Technologies, Inc.
16.3. Becton, Dickinson and Company (BD)
16.4. Bio-Rad Laboratories, Inc.
16.5. bioMérieux SA
16.6. Danaher Corporation
16.7. F. Hoffmann-La Roche Ltd.
16.8. Hologic, Inc.
16.9. Merck KGaA
16.10. PerkinElmer, Inc.
16.11. QIAGEN N.V.
16.12. Siemens Healthineers AG
16.13. Thermo Fisher Scientific Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Nucleic Acids for Molecular Diagnosis Market, Years Considered for the Study
FIGURE 2. Global Nucleic Acids for Molecular Diagnosis Market, Research Design
FIGURE 3. Global Nucleic Acids for Molecular Diagnosis Market, Research Framework
FIGURE 4. Global Nucleic Acids for Molecular Diagnosis Market, Data Triangulation
FIGURE 5. Global Nucleic Acids for Molecular Diagnosis Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2025 vs 2032 (%)
FIGURE 11. Global Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Nucleic Acids for Molecular Diagnosis Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Nucleic Acids for Molecular Diagnosis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Nucleic Acids for Molecular Diagnosis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Nucleic Acids for Molecular Diagnosis Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Nucleic Acids for Molecular Diagnosis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Nucleic Acids for Molecular Diagnosis Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Nucleic Acids for Molecular Diagnosis Market Segmentation & Coverage
TABLE 2. Global Nucleic Acids for Molecular Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 3. Global Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Microarray Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Microarray Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Microarray Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Qpcr Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Qpcr Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Qpcr Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Reagents And Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Reagents And Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Reagents And Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Microarray Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Microarray Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Microarray Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Ngs Library Preparation Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Ngs Library Preparation Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Ngs Library Preparation Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Pcr Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Pcr Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Pcr Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Bioinformatics Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Bioinformatics Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Bioinformatics Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Laboratory Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Laboratory Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Laboratory Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Sequencing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Sequencing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Sequencing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 41. Global Microarrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Microarrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Microarrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Gene Expression Arrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Gene Expression Arrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Gene Expression Arrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Genotyping Arrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Genotyping Arrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Genotyping Arrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Rna Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Rna Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Rna Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Conventional Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Conventional Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Conventional Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Digital Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Digital Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Digital Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Real-Time Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Real-Time Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Real-Time Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 75. Global Dna Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Dna Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Dna Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Cdna Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Cdna Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Cdna Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Genomic Dna Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Genomic Dna Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Genomic Dna Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Rna Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Rna Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Rna Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Microrna Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Microrna Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Microrna Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Mrna Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Mrna Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Mrna Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Carrier Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Carrier Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Carrier Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Pharmacogenomic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Pharmacogenomic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Pharmacogenomic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Predictive Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Predictive Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Predictive Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Bacterial Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Bacterial Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Bacterial Disease Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Parasitic Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Parasitic Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Parasitic Disease Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Viral Disease Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Viral Disease Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Viral Disease Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Hematological Cancer Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Hematological Cancer Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Hematological Cancer Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Solid Tumor Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Solid Tumor Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Solid Tumor Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Prenatal Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Prenatal Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Prenatal Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Invasive Prenatal Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Invasive Prenatal Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Invasive Prenatal Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Non-invasive Prenatal Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Non-invasive Prenatal Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Non-invasive Prenatal Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. Global Academic And Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Academic And Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Academic And Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Biopharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Biopharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Biopharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Nucleic Acids for Molecular Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. North America Nucleic Acids for Molecular Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. North America Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 170. North America Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 171. North America Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 172. North America Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 173. North America Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 174. North America Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 175. North America Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 176. North America Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 177. North America Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 178. North America Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 179. North America Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 180. North America Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. North America Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 182. North America Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 183. North America Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 184. North America Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 185. North America Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 188. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 189. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 190. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 191. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 192. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 193. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 194. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 195. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 196. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 197. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 198. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 200. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 201. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 202. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 203. Latin America Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 206. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 207. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 208. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 209. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 211. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 212. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 213. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 214. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 215. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 216. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 218. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 219. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 220. Europe Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 221. Europe Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 223. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 224. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 225. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 226. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 227. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 228. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 229. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 230. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 231. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 232. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 233. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 234. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 236. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 237. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 238. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 239. Middle East Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 241. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 242. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 243. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 244. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 245. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 246. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 247. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 248. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 249. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 250. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 251. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 252. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 254. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 255. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 256. Africa Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 257. Africa Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. Global Nucleic Acids for Molecular Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 259. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 260. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 261. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 262. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 263. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 264. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 266. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 267. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 268. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 269. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 270. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 271. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 272. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 273. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 274. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 275. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 276. ASEAN Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 278. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 279. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 280. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 281. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 282. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 283. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 284. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 285. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 286. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 287. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 288. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 289. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 291. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 292. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 293. GCC Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 294. GCC Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 296. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 297. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 298. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 299. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 300. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 301. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 302. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 303. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 304. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 305. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 306. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 307. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 308. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 309. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 310. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 311. European Union Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 312. European Union Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 314. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Product, 2017-2032 (USD Million)
TABLE 315. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 316. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Reagents And Kits, 2017-2032 (USD Million)
TABLE 317. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Services, 2017-2032 (USD Million)
TABLE 318. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 319. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 320. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 321. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 322. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Nucleic Acid Type, 2017-2032 (USD Million)
TABLE 323. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Dna, 2017-2032 (USD Million)
TABLE 324. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Rna, 2017-2032 (USD Million)
TABLE 325. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Application, 2017-2032 (USD Million)
TABLE 326. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 327. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 328. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 329. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by Prenatal Testing, 2017-2032 (USD Million)
TABLE 330. BRICS Nucleic Acids for Molecular Diagnosis Market Size, by End User, 2017-2032

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Merck KGaA
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Nucleic Acid Labeling Market - Global Forecast 2026-2032 - Product Image

Nucleic Acid Labeling Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Nucleic Acid Labeling Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Nucleic Acid Labeling Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 182 Pages
  • Global
From
Nucleic Acid Isolation & Purification Market Report 2026 - Product Image

Nucleic Acid Isolation & Purification Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Nucleic Acid Labeling Market Report 2026 - Product Image

Nucleic Acid Labeling Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Nucleic Acid Isolation & Purification Market - Global Forecast 2026-2032 - Product Image

Nucleic Acid Isolation & Purification Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.